Compare Enveric Biosciences Inc (ENVB) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Clear Secure Inc — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while Clear Secure Inc trades at $43.54 (market cap $4.44B). The key difference: Clear Secure Inc is far larger — about 663.7× Enveric Biosciences Inc's market cap, and Clear Secure Inc pays a 1.33% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Clear Secure Inc for 19 Days on average.
| ENVB | YOU | |
|---|---|---|
Market Cap | $6.69M | $4.44B |
Volume | 41,141 | 1,477,828 |
Sector | Health | Technology |
52-Week High | $10.80 | $62.36 |
52-Week Low | $1.27 | $29.61 |
Typical Hold Time | 14 Days | 19 Days |
Enterprise Value | -$1.60M | $3.59B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
Clear Secure (YOU) trades at $42.58, up 2.6% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with 27% revenue growth in Q2 2026, beating earnings estimates, and robust profitability margins. Recent partnership with CrowdStrike and corporate membership launch highlight growth initiatives. Analyst consensus is mixed with a $61.40 price target representing 44% upside potential.
The stock presents growth potential driven by expanding membership base and enterprise partnerships, but faces risks from competitive pressures and potential execution challenges. Current valuation at 28.77 P/E appears reasonable given growth trajectory, though technical indicators show some overbought conditions that may limit near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
